Mount Yale Investment Advisors, LLC Ultragenyx Pharmaceutical Inc. Transaction History
Mount Yale Investment Advisors, LLC
- $1.21 Billion
- Q2 2025
A detailed history of Mount Yale Investment Advisors, LLC transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Mount Yale Investment Advisors, LLC holds 1,509 shares of RARE stock, worth $52,211. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,509Holding current value
$52,211% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding RARE
# of Institutions
362Shares Held
88.2MCall Options Held
3.64MPut Options Held
2.24M-
Vanguard Group Inc Valley Forge, PA10.2MShares$353 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.6MShares$194 Million0.01% of portfolio
-
Sands Capital Management, LLC Arlington, VA3.94MShares$136 Million0.43% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.89MShares$99.9 Million0.01% of portfolio
-
Baker Bros. Advisors LP New York, NY2.77MShares$95.9 Million1.02% of portfolio
About Ultragenyx Pharmaceutical Inc.
- Ticker RARE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,036,896
- Market Cap $2.42B
- Description
- Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...